Canaccord Genuity Group upgraded shares of Aurora Cannabis (NYSE:ACB – Get Rating) from a sell rating to a hold rating in a research report released on Wednesday morning, The Fly reports.
Several other brokerages also recently weighed in on ACB. Piper Sandler dropped their price objective on Aurora Cannabis from $4.00 to $3.00 and set a neutral rating for the company in a research report on Wednesday. Cantor Fitzgerald upgraded Aurora Cannabis from a neutral rating to an overweight rating in a research report on Friday, June 24th. Finally, Stifel Nicolaus upgraded Aurora Cannabis from a sell rating to a hold rating and set a $2.15 price objective for the company in a research report on Monday, June 6th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, Aurora Cannabis has a consensus rating of Hold and an average target price of $4.30.
Get Aurora Cannabis alerts:Aurora Cannabis Stock Performance
Shares of NYSE ACB opened at $1.20 on Wednesday. The stock's fifty day moving average price is $1.52 and its two-hundred day moving average price is $2.21. The firm has a market cap of $272.16 million, a price-to-earnings ratio of -0.20 and a beta of 2.64. The company has a debt-to-equity ratio of 0.32, a current ratio of 5.85 and a quick ratio of 4.76. Aurora Cannabis has a one year low of $1.12 and a one year high of $8.69.
Hedge Funds Weigh In On Aurora Cannabis
Large investors have recently bought and sold shares of the company. ETF Managers Group LLC increased its stake in shares of Aurora Cannabis by 1.5% in the fourth quarter. ETF Managers Group LLC now owns 11,435,872 shares of the company's stock valued at $62,897,000 after buying an additional 169,935 shares during the period. Vanguard Group Inc. increased its stake in shares of Aurora Cannabis by 4.6% in the first quarter. Vanguard Group Inc. now owns 6,346,189 shares of the company's stock valued at $25,383,000 after buying an additional 281,946 shares during the period. Renaissance Technologies LLC increased its stake in shares of Aurora Cannabis by 267.4% in the second quarter. Renaissance Technologies LLC now owns 3,220,384 shares of the company's stock valued at $4,251,000 after buying an additional 2,343,884 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its stake in shares of Aurora Cannabis by 11.3% in the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,798,034 shares of the company's stock valued at $2,373,000 after buying an additional 182,139 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in shares of Aurora Cannabis by 47.1% in the first quarter. Dimensional Fund Advisors LP now owns 981,039 shares of the company's stock valued at $3,924,000 after buying an additional 313,940 shares during the period. 29.53% of the stock is currently owned by institutional investors.About Aurora Cannabis
(Get Rating)
Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.
Recommended Stories
- Get a free copy of the StockNews.com research report on Aurora Cannabis (ACB)
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.